Author:
Wenke A.,Schmidt S.,Stier-Brück I.,Stoll H.,Werner N.,Zwinge B.,Zeuzem S.,Scharrer I.
Publisher
Springer Berlin Heidelberg
Reference42 articles.
1. Aledort LM (1993) Consequences of chronic hepatitis C: a review article for the hematologist. Am J Hematol 44: 29–37
2. Alscher DM, Bode JC (1997) Therapie der Hepatitis C. Med Klinik 92: 147–161
3. Alter Mj, Margolis HS, Krawczynski K et al. (1992) The natural history of community-acquired hepatitis C in the united states. NEJM 327: 1899
4. Bell H, Hellum K, Harthug S et al. (1997) Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Scand J Infect Dis 29: 17–22
5. Bellary S, Smith DG, Bankes P, Harris A, Shayiq R, Black M (1995) High dose interferon alpha 2b therapy for chronic hepatitis C. An open label study of the response and predictors of response. Amer J Gastroenterol. 90: 259–262